|
Companies Withdrawing Drugs in EU Must Provide Reason Under New Pharmacovigilance Rules
Manufacturers withdrawing their drugs from any market in the EU will now have to notify competent authorities of the reason, according to amended pharmacovigilance rules adopted by the Council of the European Union Thursday.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives